Rallybio Corp (RLYB) is a pharmaceutical preparations company incorporated in DE, listed on the Nasdaq. With a market capitalization of $31 million, Rallybio Corp is a micro-cap company. The stock currently trades at $10.60, up 40.58% today, with a 52-week range of $1.76–$6.40.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | $-1.33 | $-1.33 | +27.7% | |
| 2023 | $-1.84 | $-1.84 | +12.0% | |
| 2022 | $-2.09 | $-2.09 | — | |
| 2021 | — | — | — |